Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Calumet Specialty Products Partners Prices Public Offering - Quick Facts

RELATED NEWS
Trade CLMT now with 
3/26/2013 9:11 AM ET

Calumet Specialty Products Partners L.P. (CLMT: Quote) announced it priced an underwritten public offering of 5.25 million common units at $37.50 per unit. Calumet also granted the underwriters a 30-day option to purchase up to 787,500 additional common units.

Calumet intends to use the net proceeds, including a proportionate capital contribution from its general partner, for general partnership purposes, including working capital, capital expenditures, acquisitions and potentially the redemption or repurchase of outstanding notes.

The offering is expected to close on April 1, 2013.

Click here to receive FREE breaking news email alerts for Calumet Specialty Products Partners L.P. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
While Republicans will try to use the troubled rollout of Obamacare to their advantage in the upcoming midterm elections, the results of a Reuters/Ipsos poll showed that Americans increasingly think Democrats have a better plan for healthcare. Nearly three hundred people are still unaccounted for after a ferry carrying 462 people capsized and sank off South Korea's southern coast, media reports citing local officials said Wednesday. The ill-fated ferry, carrying mostly high school students on an overnight trip, was heading to the tourist island of Jeju from the city of Incheon, a northwestern South Korean city that houses the country's After moving mostly higher in early trading on Wednesday, stocks have continued to perform well over the course of the session. While buying interest has waned since then open, the markets have maintained a positive bias on the day.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.